Kunshan RiboQuark Pharmaceutical Technology
Kunshan
About Kunshan RiboQuark Pharmaceutical Technology
Kunshan RiboQuark Pharmaceutical Technology Co., Ltd. develops siRNA based preclinical drug candidates. Its products include QPI-1007, an ocular neuroprotectant. The company also develops siRNA-based cosmetic product for the prevention of hair loss. The company was founded in 2012 and is based in Kunshan, China.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $7.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2014)
Industries & Categories
Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/kunshan-riboquark-pharmaceutical-technology-2771203 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.